株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

舞踏病:世界の治験レビュー

Chorea Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 306650
出版日 ページ情報 英文 46 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.99円で換算しております。
Back to Top
舞踏病:世界の治験レビュー Chorea Global Clinical Trials Review, H1, 2017
出版日: 2017年06月30日 ページ情報: 英文 46 Pages
概要

当レポートでは、舞踏病に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、G7諸国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤の比較といった情報を盛り込んで、お届けします。

目次

イントロダクション

  • 舞踏病
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数

G7諸国における治験件数:中枢神経系治験に対する舞踏病治験件数比率

G7諸国における治験件数:フェーズ(相)別

G7諸国における治験件数:進捗状況別

治験件数:フェーズ(相)別

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

評価項目別の治験件数

未完了の治験

一定期間に採用された被験者数

スポンサーの種類別の治験件数

有望なスポンサー

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Auspex Pharmaceuticals, Inc.
    • Prestwick Pharmaceuticals, Inc.
    • Novartis AG
  • 代表的な研究機関病院の治験の概要
    • National Institute of Neurological Disorders and Stroke
    • The University of Iowa
    • 東北大学大学院医学系研究科・医学部
    • The Sheba Medical Center
    • University of Cape Town
    • National Heart, Lung, and Blood Institute

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC4278CTIDB

GlobalData's clinical trial report, "Chorea Global Clinical Trials Review, H1, 2017" provides an overview of Chorea clinical trials scenario. This report provides top line data relating to the clinical trials on Chorea. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Chorea to Central Nervous System Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 16
  • Clinical Trials in G7 Countries by Trial Status 17
  • Clinical Trials by E7 Countries: Proportion of Chorea to Central Nervous System Clinical Trials 18
  • Clinical Trials by Phase in E7 Countries 20
  • Clinical Trials in E7 Countries by Trial Status 21
  • Clinical Trials by Phase 22
  • In Progress Trials by Phase 23
  • Clinical Trials by Trial Status 24
  • Clinical Trials by End Point Status 25
  • Subjects Recruited Over a Period of Time 26
  • Clinical Trials by Sponsor Type 27
  • Prominent Sponsors 28
  • Top Companies Participating in Chorea Therapeutics Clinical Trials 29
  • Prominent Drugs 30
  • Latest Clinical Trials News on Chorea 31
  • Jun 01, 2017: Teva to Present Data on Deutetrabenazine at the 21st International Congress of Parkinson's Disease and Movement Disorders 31
  • Clinical Trial Profile Snapshots 32

Appendix 44

  • Abbreviations 44
  • Definitions 44
  • Research Methodology 45
  • Secondary Research 45
  • About GlobalData 46
  • Contact Us 46
  • Source 46

List of Tables

List of Tables

  • Chorea Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Chorea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Chorea Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Chorea Therapeutics Clinical Trials, Europe, Top Countries, 2017* 11
  • Chorea Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Chorea Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Chorea to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 15
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Chorea to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 19
  • Chorea Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Chorea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Chorea Therapeutics, Global, Clinical Trials by Phase, 2017* 22
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
  • Chorea Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Chorea Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Chorea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Chorea Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
  • Chorea Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Chorea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Chorea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30

List of Figures

List of Figures

  • Chorea Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Chorea Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Chorea Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2017* 10
  • Chorea Therapeutics Clinical Trials, Europe, Top Countries (%), 2017* 11
  • Chorea Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12
  • Chorea Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 13
  • Proportion of Chorea to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 14
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16
  • Chorea Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17
  • Proportion of Chorea to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 18
  • Chorea Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
  • Chorea Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
  • Chorea Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
  • Chorea Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
  • Chorea Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
  • Chorea Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
  • Chorea Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
  • Chorea Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
  • Chorea Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
  • Chorea Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
  • Chorea Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
  • GlobalData Methodology 45
Back to Top